Get notified when JAGX files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsJaguar Health adjourns annual meeting after Nasdaq discussions, exchanges preferred stock
Filed May 22, 2026 · Period ending May 21, 2026 · ~1 min read
Key Changes
-
high
Company adjourned 2026 Annual Meeting from May 22 to June 2 following discussions with Nasdaq staff, will file proxy supplement with additional information before stockholders vote on proposals.
Item 5.07 view on EDGAR → -
high
Nasdaq discussions prompted need for additional disclosure to stockholders regarding certain proxy proposals, though specific issues were not disclosed in the filing.
Item 5.07 view on EDGAR → -
medium
Exchanged 7.96 shares of Series Q Preferred Stock for 54,222 common shares with Streeterville Capital on May 21, increasing common shares outstanding and potentially diluting existing shareholders.
Item 3.02 view on EDGAR →
1 more material change behind this preview — plus the full narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.
Want to see a complete report first? Today's free report (ADMT 10-K) is open in full — no account needed.
Partner
Trade JAGX commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
Thanks — your feedback helps us improve report quality.
Source-verified from EDGAR · Narrative written by AI · May 23, 2026 · How we verify